Addison Pierce

Associate
Full contact info

Experience

Clearside Biomedical – $65 Million Royalty Interest Purchase and Sale Agreement

September 22, 2022

Cooley advised Clearside Biomedical on its $65 million royalty interest purchase and sale agreement with HealthCare Royalty Partners. Debt finance partner Michael Tollini led the Cooley team advising Clearside, a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

Related contacts

Michael Tollini
Partner, Washington DC
Addison Pierce
Associate, Chicago

Related Practices & Industries

Sixth Street Invests in Blueprint Medicines

July 7, 2022

Cooley advised global investment firm Sixth Street on its strategic investment in Blueprint Medicines, a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Lawyers Mischi a Marca, Matt Browne, Matt Scarano, Addison Pierce, Matt Kong and Nick Neuteufel led the Cooley team advising Sixth Street. 

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Matt Browne
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Michael Tuscan
Partner, Washington DC
Jon Cousin
Associate, Washington DC
Tanya Heare-Rowlands
Special Counsel, London
Matthew Everhart
Patent Agent, Washington DC
Jeffery Wyzykowski
Patent Agent, Washington DC
Matthew Scheideman
Patent Agent, Washington DC
Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Zack Gong
Associate, Shanghai
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Elizabeth Anne Wright
Partner, Brussels
Aaron Pomeroy
Partner, Colorado
Michael Klein
Partner, New York
Paul Springer
Associate, New York
Megan Browdie
Partner, Washington DC
Howard Morse
Partner, Washington DC

Related Practices & Industries

Rothy's Enters Strategic Investment Agreement With Alpargatas

December 29, 2021

Cooley advised sustainable lifestyle brand Rothy’s in connection with its strategic investment from Brazilian footwear brand Alpargatas to fuel global growth and expand vertically integrated operations. The transaction will result in a post-investment valuation of $1 billion. Lawyers Jodie Bourdet, Al Browne, Lindsy Solanki, Farzad Tabaee and Meera Patel led the Cooley team advising Rothy’s.

Read more

Related contacts

Jodie Bourdet
Partner, San Francisco
Alfred Browne
Partner, Boston
Lindsy Solanki
Associate, Palo Alto
Farzad Tabaee
Associate, San Francisco
Meera Patel
Associate, San Francisco
Ron Metzger
Paralegal Specialist, San Francisco
Sharon Connaughton
Special Counsel, Washington DC
Megan Browdie
Partner, Washington DC
Christopher Kimball
Partner, Washington DC
Stacey A. Bradford
Special Counsel, Washington DC
Erica Russell
Associate, San Francisco
Tara Capsuto
Associate, San Francisco
Nicollette R. Kirby
Associate, Washington DC
Sarah Oliai
Associate, Washington DC
Madeleine Smith
Associate, San Francisco
Addison Pierce
Associate, Chicago

Related Practices & Industries

Vera Therapeutics Closes $50 Million Debt Financing

December 18, 2021

Cooley advised Vera Therapeutics on its $50 Million debt facility with Oxford Finance. Vera, whose shares trade on the Nasdaq Global Market under the symbol VERA, is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Partner Patrick Flanagan led the Cooley team.

Related contacts

Patrick Flanagan
Partner, New York
Addison Pierce
Associate, Chicago
Xueqing Li
Associate, San Francisco

Related Practices & Industries

Rapid7 Closes $100 Million Secured Credit Facility

December 23, 2021

Cooley advised Rapid7 on an amendment to its credit and security agreement, with KeyBank National Association as administrative agent; Rapid7’s wholly-owned subsidiary, Rapid7 LLC as co-borrower; and the lenders party thereto. The amended credit agreement provides for a $100 million revolving credit facility and an accordion feature under which Rapid7 can increase the credit facility to up to $150 million. Partner Patrick Flanagan led the Cooley team advising Rapid7, which trades on the NASDAQ Global Market under the symbol RPD. Rapid7 is a leading cyber security solutions provider, on a mission to make successful security tools and practices accessible to all.

Related contacts

Patrick Flanagan
Partner, New York
Addison Pierce
Associate, Chicago
Savannah Harms
Associate, New York

Related Practices & Industries

View more